CN1058620C - Yingfengaidi medicine and its production process - Google Patents
Yingfengaidi medicine and its production process Download PDFInfo
- Publication number
- CN1058620C CN1058620C CN95119652A CN95119652A CN1058620C CN 1058620 C CN1058620 C CN 1058620C CN 95119652 A CN95119652 A CN 95119652A CN 95119652 A CN95119652 A CN 95119652A CN 1058620 C CN1058620 C CN 1058620C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- flos
- cancer
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a novel medicine for external application and with special effects on treating exposure cancer, and a production process of powder, ointment and plasters of the medicine. The medicine is prepared from datura flower, yellow azalea flower, olibanum, myrrh, sal ammoniac, arsenic, mercury, orpiment, kansui root, spurge, genkwa flower, rhubarb, centipede, blister beetle, nux vomica, natural indigo, snakegourd root, sphene, websterite, rosin and borneol as raw materials. According to the requirements of different medicine forms, the raw materials are respectively processed, pulverized, fried, decocted and proportionally prepared into the powder, the ointment and the plasters. The medicine of the present invention not only is suitable for the early treatment of the exposure cancer, but also is more suitable for middle and late exposure cancer and has better effect.
Description
The present invention is a kind of cancer external used medicine, and it is that the raw material outfit processes with multiple Chinese herbal medicine, and the treatment malignant tumor has the Chinese medicine for outer use of special-effect.
The present invention also provides this drug powder, the outfit production technology of ointment, plaster.
The pernicious swollen surgical intervention modern medicine that stays is with operation, and radiotherapy is main, has obtained the comparatively outstanding relief of symptoms or the effect of part clinical cure, relative prolongation patient's life span.But weak point is exactly a centering, and patient with advanced cancer particularly has the outgrowth patient's curability of extensive diffusive little, even feels simply helpless, and cure rate is low, the disability rate height, and life span is short, and recurrence is difficult to avoid.
Motherland's medical science has long history to the external medication of tumor (comprising pernicious swollen staying), through constantly bringing forth new ideas of successive dynasties physician, many square famous medicines have been produced, modern Application also can obtain certain curative effect in the external treatment of malignant tumor, as " Ruizhutang Jingyan Fang, Empirical Recipes from Auspicious Bamboo Hall " it " keeping normal life activities spindle ", " Waike Zhengzong, Orthodox Manual of External Diseases " it " rifle of three products ", " Standards of Diagnosis and Treatment " it " letter; imitate spindle ", Golden Mirror of Medicine it " combustion of ice spiral shell ", " anticancer herbal drug preparation " it " controlling cancer looses ", it " urges Beijing cervical cancer cooperative groups and takes off nail " etc. and all can obtain certain curative effect, but still exists weak point.
(1) zest is big, can occur pain in various degree after the medication, even severe pain, brings the patient insufferable misery.
(2) because the general wound surface of malignant tumor is bigger, the little then treatment of dosage is not thorough, and toxic and side effects greatly then often takes place dosage.As dizziness, nausea,vomiting,diarrhea etc.
(3) normal structure is damaged, make wound surface be difficult for healing, very the person promotes canceration to worsen rapidly.
(4) there is the cure rate of friendship low.Above-mentioned in addition every defective is so the adopter is few at present.
Malignant tumor takes place and the basis of development is that body physiological function and benefit materials are deficient.Only extraneous carcinogen just can be had an opportunity in the intrusive body to combine with canceration guiding material and carcinogen in the body and caused harm under the deficient condition of body physiological function and benefit materials.Even after the carcinous generation of cancerating, if body physiological function and benefit materials are restored and improve, pathological changes is also with controlled reverse.
The pernicious swollen real cause of disease of staying generation is that numerous extraneous carcinogen mixes and invades behind the body back that combines with body physiological guiding material and/or pathologic carcinogen and produce a mutagenesis cancer poison (MCP) that discharges.It is a kind of composition special changeable, destroy and to cause the stupid malicious mixture of multielement that degeneration can be extremely strong, promptly not easy to identify, also be difficult to separate, more not formidable.
The pathomechanism that the malignant neoplasm tumour development worsens is the material alluvial.In a single day canceration forms, the cell overlap extruding, and body fluid is the stagnant state of high agglutinated, and the passages through which vital energy circulates pipeline is obstructed, and material circulation slows down, and nutrition non-nutritious matters such as gas, blood, water, expectorant, poison deposit gradually.Alluvial to the utmost point, certainly will explosion fester, spread hypertrophy.
Therefore, carcinous cancerate void is arranged, poison becomes silted up three big general character.To thoroughly cure cancer must capture this three big general character can not.Principal contradiction is resolved, certainly wants contradiction also just to be readily solved.JINHUA is pasted to restraining this three big general character of elimination and is designed.
Mutagenesis cancer poison and other oncofetal substance are removed in the direct or indirect elimination of medicine energy of the present invention, slow down overlapping extruding, dissolve the material alluvial.Cancer pain there is special analgesic effect.Not only to normal structure without any injury, and cancerous cell had very strong liquefaction decomposition.Can remove focus within a short period of time, promote that wound surface heals early.Not only, have no side effect, and body reason function and benefit materials are had the promotion recovery and strengthen the effect that improves not injury of human body.Therefore, this medicine external curing treatment of cancer is thorough, and effectively the cure rate height recurs after healing, and life span is long, and life span is long, and life quality is good, is the treatment new technique that the cancer surgery has world lead level.
The purpose of this invention is to provide a kind of treatment that is widely used in the early, middle and late phase patient of cancer, cancerous pain is had special remission effect.Oncofetal substance there is good elimination to remove ability and normal structure is had no injury, also do not cause toxicity, thorough treatment, effective cure rate height does not recur after more, and life span is long, and life quality is good controls the cancer topical agent.
A further object of the present invention just provides the outfit production technology of this drug powder, ointment, plaster.
The present invention follows the theory of the combination of Chinese and Western medicine and the viewpoint of whole unification, the method of disease medication is distinguished in utilization modern study achievement and differential diagnosis of diseases, characteristics according to the carcinous three big general character that cancerate, select the natural Chinese medicinal herb that counteracting toxic substances restrains cancer, change silt dispersing tumor, sets upright post-equalization, by theory of Chinese medical science and the preparation of modern study prescription.
The optimum formula amounts of components ratio of medicine of the present invention is
Flos Daturae 20 Flos Rhododendri Mollis 20 Olibanums 60 Myrrhas 60
Sal Ammoniacus 30 Arsenicum sablimatum 1.2 hydrargyrums 15 Realgars 15
Radix Kansui 20 Radixs Euphorbiae Pekinensis 20 Flos Genkwas, 20 Radix Et Rhizoma Rhei 60
Scolopendra 60 Mylabris 3 Semen Strychni 30 Indigo Naturaliss 60
Radix Trichosanthis 60 Sal Nitri 45 Alumen 45 Colophonium 45
Borneolum Syntheticum 20
Effective recipe ingredient usage ratio of medicine of the present invention is
Flos Daturae 15 Flos Rhododendri Mollis 15 Olibanums 45 Myrrhas 45
Sal Ammoniacus 20 Arsenicum sablimatum 1 hydrargyrum 10 Realgars 10
Radix Kansui 15 Radixs Euphorbiae Pekinensis 15 Flos Genkwas, 15 Radix Et Rhizoma Rhei 45
Scolopendra 30 Mylabris 2 Semen Strychni 20 Indigo Naturaliss 60
Radix Trichosanthis 60 Sal Nitri 30 Alumen 30 Colophonium 30
Borneolum Syntheticum 15
The maximum constraints recipe ingredient ratio of medicine of the present invention is
Flos Daturae 30 Flos Rhododendri Mollis 30 Olibanums 90 Myrrhas 90
Sal Ammoniacus 45 Arsenicum sablimatum 1.5 hydrargyrums 20 Realgars 20
Radix Kansui 30 Radixs Euphorbiae Pekinensis 30 Flos Genkwas, 30 Radix Et Rhizoma Rhei 90
Scolopendra 90 Mylabris 4.5 Semen Strychni 45 Indigo Naturaliss 90
Radix Trichosanthis 100 Sal Nitri 75 Alumen 75 Colophonium 60
Borneolum Syntheticum 45
The outfit production technology of drug powder of the present invention is
1. all medicine is given birth to usefulness, must not concoct.
With Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, Scolopendra, Mylabris, Semen Strychni, Indigo Naturalis, Radix Trichosanthis according to a conventional method processing powder be broken into 60 order fine powders.
3. get above-mentioned medicated powder 1/2 amount and mix with Sal Ammoniacus, Arsenicum sablimatum, Realgar, Sal Nitri, Alumen, Borneolum Syntheticum and mix thoroughly, be ground into 100 order fine powders.
4. get 1/2 remaining amount of second gained medicated powder and mix with Olibanum, Myrrha, hydrargyrum, Colophonium and mix thoroughly, be ground into 100 order fine powders.If bulk occurs, be about to block medicated powder and after abundant xeothermic drying below 60 ℃, be ground into 100 order fine powders again during pulverizing.
5. cross the 2-3 time through 100 mesh sieves again after third and fourth gained 100 order fine powders mixing being mixed thoroughly, reach the purpose that gram divides and spares.
With the 5th gained medicated powder through 150 ℃ of dry heat sterilization 60-90 minute postcooling, with paraffin paper subpackage sealing, plastics are packed, every paraffin paper bag 50 grams, every plastic bag 10 paraffin paper bags.
The outfit production technology of drug ointment of the present invention is
1. all medicine is given birth to usefulness, need not concoct.
With Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, Scolopendra, Mylabris, Semen Strychni, Radix Trichosanthis according to a conventional method processing powder be broken into behind the 60 order powder to mix and process fine powder according to a conventional method and become 100 order fine powders standby with Sal Ammoniacus, Arsenicum sablimatum, Realgar, Indigo Naturalis, Sal Nitri, Alumen.
3. get cotton oil and put into marmite for 2500 milliliters, be fried boiling with high heat, add Olibanum, Myrrha, hydrargyrum, Colophonium, use two-layer filtered through gauze while hot after allowing it fully dissolve.
4. filtrate is simmered in water again and boil, add second gained medicated powder, fully mix thoroughly.The adding Borneolum Syntheticum dissolves and mixes well behind fire, and the bottling sealing of cooling back is standby.
The outfit production technology of medicine plaster of the present invention is
1. all medicine is given birth to usefulness, need not concoct.
2. it is standby Radix Kansui, the Radix Euphorbiae Pekinensis, Radix Et Rhizoma Rhei, Semen Strychni, Radix Trichosanthis to be processed into decoction pieces according to a conventional method.
With Sal Ammoniacus, Arsenicum sablimatum, Realgar, Sal Nitri, Alumen, Indigo Naturalis according to a conventional method processing powder be broken into behind the 100 order fine powders mix with hydrargyrum mix thoroughly standby.
4. getting Oleum Sesami puts into marmite for 2000 milliliters and is fried boiling with high heat, add that Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, joy centipede, Mylabris, Semen Strychni, Radix Trichosanthis are fried to be sallow or coke black to medicine, remove medicinal residues, add Olibanum again, Myrrha, Colophonium dissolve the two-layer filtered through gauze in back.
Filtrate with slow fire continue to decoct to splash into can be shaped in the cold water but not solid for the degree.Add the 3rd gained medicated powder, behind fire, add Borneolum Syntheticum again, fully mix thoroughly, be spread out in while hot on the things such as paper, cloth, skin.The area that spreads out is neglected the extent of disease size greatly and is decided.
The usage and the consumption of medicine external curing cancer of the present invention are
1. powder: be mainly used in the cancer more person of pus of festering, every 1cm
2Medication powder 0.5 gram is spread on wound surface, and the cotton pad of gauze applies lid, uses immobilization with adhesive tape, changes dressings once every 12 hours.The drug of topical application will note avoiding normal structure.
2. ointment: be mainly used in wound surface drying person after the cancer diabrosis, every 1cm
2Medication 0.8 gram spreads out uniformly, and the cotton pad of gauze applies lid, uses immobilization with adhesive tape, changes dressings once every 12 hours, and the drug of topical application will note avoiding normal structure.
3. plaster: be mainly used in not diabrosis person of cancer.By the big or small plaster outer plaster of selecting to adapt very much not of lump.Changed dressings once every 24 hours.Plaster powder size must not surpass the area of pernicious lump.
Drug study of the present invention studies have shown that following pharmacological action:
1. the carcinous tissue that cancerates of liquefaction disintegrate promotes the necrosis of carninomatosis kitchen range to come off.
2. special analgesic effect is arranged.Compare with traditional external corrosion counteracting toxic substances method, this is one of the most outstanding effect of the present invention.
3. cancerous cell there is the stronger lethal effect of living that presses down, can antagonism is carcinous cancerates.
4. improve material circulation and nutrition supply, improve the regeneration compensatory capacity of wound surface normal structure and cell, promote to repair.
5. sterilization, antivirus action are widely arranged, help the reverse conversion of cancer.
The author uses Drug therapy of the present invention and exposes the property cancer and obtained the focus disintegrate and remove thoroughly, and it is good with sequela, healing to have no side effect, and the cure rate height, does not recur the art therapy effect that life quality is good after more.Medicine of the present invention not only adapts to the early stage external curing of cancer, and the external curing of centering, patient with advanced cancer is even more ideal.Now with complete data, follow up a case by regular visits to really, use separately behind the cured substance of the present invention healthy existence more than 7 years person's 73 examples sum up as after, to confirm the fancy effect of medicine of the present invention to exposure property cancer external curing.
73 examples are all made a definite diagnosis through detections such as X line, B ultrasonic, CT, endoscope, histiocyte biopsies, man's 33 examples wherein, Ms's 40 examples.The oldest person 58 years old, age reckling 18 years old.Early-stage cancer 17 examples, mid-term cancer 31 examples, terminal cancer 25 examples.Skin carcinoma 13 examples, kindred 9 examples that swell, the cerebral tumor 4 examples, mammary cancer 11 example, thyroid carcinoma 4 examples, canceration of ulcer 5 examples, cervical cancer 10 example, lip cancer 3 examples, lymphosarcoma 11 examples, melanotic nevus canceration 3 examples.
Administrated method: no matter be early-stage cancer, still in, terminal cancer, diabrosis person does not use medicine plaster of the present invention, the more person of the pus that festers uses drug powder of the present invention, diabrosis drying person uses drug ointment of the present invention.
Therapeutic outcome: it is multiple through the X line that all case is cured the back, and B ultrasonic, CT endoscope, histiocyte biopsy etc. detect no abnormal.
1. early-stage cancer average time of the complete disintegrate elimination of tumor is 85 days, and mid-term, cancer was 63 days, and terminal cancer is 56 days.The complete disintegrate of various cancers is removed and is seen Table 1 average time.
2. healing early-stage cancer average time is 410 days, and mid-term, cancer was 662 days, and terminal cancer is 725 days.The healing of various cancers sees Table 2 average time.
3. curing back healthy existence early-stage cancer average time is 2980 days, and mid-term, cancer was 3302 days, and terminal cancer is 2865 days.See Table 3 the average time that various cancers is cured the healthy existence in back.
4. antisecosis situation operate as normal person 26 examples, self-care person's 35 examples fully of living, life partial self-help person 12 examples.Various cancers is cured back antisecosis situation and is seen Table 4.
Table 1, the average time that the complete disintegrate of various cancers tumor is removed
| Various cancers | Total routine number | In early days | Mid-term | Late period | ||||||||||||||||||
| Example | 30 days | ％ | 60 days | ％ | 90 days | ％ | Example | 30 days | ％ | 60 days | ％ | 90 days | ％ | Example | 30 days | ％ | 60 days | ％ | 90 days | ％ | ||
| Skin carcinoma | 13 | 6 | 1 | 16.7 | 3 | 50 | 2 | 33.3 | 5 | 2 | 40 | 2 | 40 | 1 | 20 | 2 | 1 | 50 | 1 | 50 | ||
| Osteosarcoma | 9 | 2 | 1 | 50 | 1 | 50 | 2 | 2 | 100 | 5 | 2 | 40 | 2 | 40 | 1 | 20 | ||||||
| The cerebral tumor | 4 | 3 | 2 | 66.6 | 1 | 33.4 | 1 | 1 | 100 | |||||||||||||
| Breast carcinoma | 11 | 5 | 2 | 40 | 3 | 60 | 4 | 1 | 25 | 2 | 50 | 1 | 25 | 2 | 2 | 100 | ||||||
| Thyroid carcinoma | 4 | 3 | 2 | 66.6 | 1 | 33.4 | 1 | 1 | 100 | |||||||||||||
| Canceration of ulcer | 5 | 2 | 2 | 100 | 3 | 2 | 66.6 | 1 | 33.3 | |||||||||||||
| Cervical cancer | 10 | 6 | 1 | 16.7 | 3 | 50 | 2 | 33.3 | 4 | 1 | 25 | 2 | 50 | 1 | 25 | |||||||
| Lip cancer | 3 | 1 | 1 | 100 | 2 | 1 | 50 | 1 | 50 | |||||||||||||
| Lymphosarcoma | 11 | 3 | 2 | 66.6 | 1 | 33.4 | 2 | 1 | 50 | 1 | 50 | 6 | 2 | 33.3 | 3 | 50 | 1 | 16.7 | ||||
| The melanotic nevus canceration | 3 | 3 | 1 | 33.3 | 2 | 66.7 | ||||||||||||||||
The healing average time of table 2 various cancers
| Various cancers | Total routine number | In early days | Mid-term | Late period | ||||||||||||||||||
| Example | 1 year | ％ | 2 years | ％ | 3 years | ％ | Example | 1 year | ％ | 2 years | ％ | 3 years | ％ | Example | 1 year | ％ | 2 years | ％ | 3 years | ％ | ||
| Skin carcinoma | 13 | 6 | 3 | 50 | 2 | 33.3 | 1 | 16.7 | 5 | 2 | 40 | 2 | 40 | 1 | 20 | 2 | 2 | 100 | ||||
| Osteosarcoma | 9 | 2 | 2 | 100 | 2 | 1 | 50 | 1 | 50 | 5 | 2 | 40 | 3 | 60 | ||||||||
| The cerebral tumor | 4 | 3 | 1 | 33.3 | 2 | 66.7 | 1 | 1 | 100 | |||||||||||||
| Breast carcinoma | 11 | 5 | 3 | 60 | 2 | 40 | 4 | 3 | 75 | 1 | 25 | 2 | 2 | 100 | ||||||||
| Thyroid carcinoma | 4 | 3 | 1 | 33.3 | 2 | 66.7 | 1 | 1 | 100 | |||||||||||||
| Canceration of ulcer | 5 | 2 | 1 | 50 | 1 | 50 | 3 | 1 | 33.4 | 2 | 66.6 | |||||||||||
| Cervical cancer | 10 | 6 | 4 | 66.6 | 2 | 33.4 | 4 | 1 | 25 | 3 | 75 | |||||||||||
| Lip cancer | 3 | 1 | 1 | 100 | 2 | 1 | 50 | 1 | 50 | |||||||||||||
| Lymphosarcoma | 11 | 3 | 2 | 66.6 | 1 | 33.4 | 2 | 2 | 100 | 6 | 1 | 16.7 | 2 | 33.3 | 3 | 50 | ||||||
| The melanotic nevus canceration | 3 | 3 | 1 | 33.3 | 1 | 33.3 | 1 | 33.4 | ||||||||||||||
Table 3 various cancers is cured the average time of the healthy existence in back
| Various cancers | Total routine number | In early days | Mid-term | Late period | ||||||||||||||||||
| Example | 7 years | ％ | 10 years | ％ | 12 years | ％ | Example | 7 years | ％ | 10 years | ％ | 12 years | ％ | Example | 7 years | ％ | 10 years | ％ | 12 years | ％ | ||
| Skin carcinoma | 13 | 6 | 4 | 66.6 | 2 | 33.4 | 5 | 1 | 20 | 3 | 60 | 1 | 20 | 2 | 1 | 50 | 1 | 50 | ||||
| Osteosarcoma | 9 | 2 | 1 | 50 | 1 | 50 | 2 | 2 | 100 | 5 | 3 | 60 | 2 | 40 | ||||||||
| The cerebral tumor | 4 | 3 | 2 | 66.6 | 1 | 33.4 | 1 | 1 | 100 | |||||||||||||
| Breast carcinoma | 11 | 5 | 1 | 20 | 2 | 40 | 2 | 40 | 4 | 3 | 75 | 1 | 25 | 2 | 1 | 50 | 1 | 50 | ||||
| Thyroid carcinoma | 4 | 3 | 3 | 100 | 1 | 1 | 100 | |||||||||||||||
| Canceration of ulcer | 5 | 2 | 2 | 100 | 3 | 3 | 100 | |||||||||||||||
| Cervical cancer | 10 | 6 | 2 | 33.3 | 2 | 33.3 | 2 | 33.4 | 4 | 3 | 75 | 1 | 25 | |||||||||
| Lip cancer | 3 | 1 | 1 | 100 | 2 | 2 | 100 | |||||||||||||||
| Lymphosarcoma | 11 | 3 | 1 | 33.3 | 2 | 66.7 | 2 | 2 | 100 | 6 | 3 | 50 | 2 | 33.3 | 1 | 16.7 | ||||||
| The melanotic nevus canceration | 3 | 3 | 2 | 66.6 | 1 | 33.3 | ||||||||||||||||
Table 4 various cancers is cured back antisecosis situation
| Various cancers | Total routine number | In early days | Mid-term | Late period | ||||||||||||||||||
| Example | 0 grade | ％ | 1 grade | ％ | 2 grades | ％ | Example | 0 grade | ％ | 1 grade | ％ | 2 grades | ％ | Example | 0 grade | ％ | 1 grade | ％ | 2 grades | ％ | ||
| Skin carcinoma | 13 | 6 | 5 | 83.3 | 1 | 16.7 | 5 | 3 | 60 | 1 | 20 | 1 | 20 | 2 | 1 | 50 | 1 | 50 | ||||
| Osteosarcoma | 9 | 2 | 2 | 100 | 2 | 2 | 100 | 5 | 1 | 20 | 2 | 40 | 2 | 40 | ||||||||
| The cerebral tumor | 4 | 3 | 2 | 66.6 | 1 | 33.4 | 1 | 1 | 100 | |||||||||||||
| Breast carcinoma | 11 | 5 | 1 | 20 | 4 | 80 | 4 | 2 | 50 | 2 | 50 | 2 | 1 | 50 | 1 | 50 | ||||||
| Thyroid carcinoma | 4 | 3 | 2 | 66.6 | 1 | 33.4 | 1 | 1 | 100 | |||||||||||||
| Canceration of ulcer | 5 | 2 | 1 | 50 | 1 | 50 | 3 | 2 | 66.6 | 1 | 33.4 | |||||||||||
| Cervical cancer | 10 | 6 | 4 | 60 | 2 | 40 | 4 | 1 | 25 | 3 | 75 | |||||||||||
| Lip cancer | 3 | 1 | 1 | 100 | 2 | 1 | 50 | 1 | 50 | |||||||||||||
| Lymphosarcoma | 11 | 3 | 2 | 66.6 | 1 | 33.3 | 2 | 2 | 100 | 6 | 2 | 33.3 | 3 | 50 | 1 | 16.7 | ||||||
| The melanotic nevus canceration | 3 | 3 | 1 | 33.3 | 2 | 66.7 | ||||||||||||||||
Illustrate: in the table 40 grade: can operate as normal; 1 grade: life can be taken care of oneself fully; 2 grades: life partial self-help.
Clinical drug application result of the present invention shows that this medicine external curing exposure property cancer has following advantage:
1. each component of medicine of the present invention meets the pharmaceutical control law regulation.
2. it is early stage that medicine of the present invention not only is adapted to canceration, in more being adapted to, patient with advanced cancer.
3. medicine of the present invention can be removed overlapping extruding, and the dredging the meridian pipeline has special analgesic effect to cancer pain.
4. medicine of the present invention comes into force soon, and it is thorough that the carninomatosis kitchen range is removed in disintegrate, and the cure rate height does not recur after healing, and life span is long, and life quality is good.
5. without any injury, toxicity is slight, does not disable to human body for medicine of the present invention.Be the outstanding person in the cancer medicine for external use.
Claims (7)
1, a kind of external Chinese patent medicine for the treatment of cancer is characterized in that it is the medicament that is produced by following ratio processing preparation
Flos Daturae 15 Flos Rhododendri Mollis 15 Olibanums 45 Myrrhas 45
Sal Ammoniacus 20 Arsenicum sablimatum 1 hydrargyrum 10 Realgars 10
Radix Kansui 15 Radixs Euphorbiae Pekinensis 15 Flos Genkwas, 15 Radix Et Rhizoma Rhei 45
Scolopendra 30 Mylabris 2 Semen Strychni 20 Indigo Naturaliss 60
Radix Trichosanthis 60 Sal Nitri 30 Alumen 30 Colophonium 30
Borneolum Syntheticum 15.
2,, it is characterized in that said pharmaceutical dosage form is a powder according to the described medicine of claim 1.
3,, it is characterized in that said pharmaceutical dosage form is an ointment according to the described medicine of claim 1.
4,, it is characterized in that said pharmaceutical dosage form is a plaster according to the described medicine of claim 1.
5, the outfit production technology of the described drug powder of claim 2, it is characterized in that earlier with Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, Scolopendra, Mylabris, Semen Strychni, Indigo Naturalis, Radix Trichosanthis according to a conventional method processing powder be broken into to mix with Sal Ammoniacus, Arsenicum sablimatum, Realgar, Alumen, Sal Nitri, Borneolum Syntheticum and Olibanum, Myrrha, hydrargyrum, Colophonium respectively behind the 60 order fine powders and mix thoroughly, be ground into 100 fine powders again, fully with even, through 150 ℃ of dry heat sterilization 60-90 minutes, with paraffin paper subpackage sealing, every bag 50 grams.
6, the outfit production technology of the described drug ointment of claim 3, it is characterized in that Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, Scolopendra, Mylabris, Semen Strychni, Radix Trichosanthis processing powder according to a conventional method is broken into behind the 60 order powder and Sal Ammoniacus, Arsenicum sablimatum, Realgar, Indigo Naturalis, Sal Nitri, Alumen mixes, reprocessing is ground into 100 fine powders, get cotton oil and put into marmite for 2500 milliliters, be fried boiling with high heat, add Olibanum, Myrrha, hydrargyrum, Colophonium, use two layers of filtered through gauze after allowing it dissolve while hot, filtrate is fried boiling with slow fire again, add above-mentioned be ground into 100 orders after gained medicated powder mix thoroughly, the adding Borneolum Syntheticum dissolves and mixes well behind fire, and the bottling of cooling back promptly.
7, the outfit production technology of the described medicine plaster of claim 4, it is characterized in that Radix Kansui, the Radix Euphorbiae Pekinensis, Semen Strychni, Radix Trichosanthis is processed into decoction pieces routinely, with Sal Ammoniacus, Arsenicum sablimatum, Realgar, Sal Nitri, Alumen, Indigo Naturalis processing powder according to a conventional method is broken into behind 100 fine powders to mix with hydrargyrum and mixes thoroughly, getting Oleum Sesami puts into marmite for 2000 milliliters and is fried boiling with high heat, add Flos Daturae, Flos Rhododendri Mollis, Radix Kansui, the Radix Euphorbiae Pekinensis, Flos Genkwa, Radix Et Rhizoma Rhei, Scolopendra, Chinese blister beetle of class, Semen Strychni, Radix Trichosanthis is fried to be coke yellow or coke black to medicine, remove medicinal residues, add Olibanum again, Myrrha, Colophonium dissolves, filter with two-layer yarn while hot, filtrate with slow fire continue to decoct to splash into can be shaped in the water and not solid for the degree, adding mixes back gained medicated powder with hydrargyrum, behind fire, add Borneolum Syntheticum again, fully mix thoroughly, be spread out in paper while hot, cloth, on the skin promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95119652A CN1058620C (en) | 1995-11-12 | 1995-11-12 | Yingfengaidi medicine and its production process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95119652A CN1058620C (en) | 1995-11-12 | 1995-11-12 | Yingfengaidi medicine and its production process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1131037A CN1131037A (en) | 1996-09-18 |
| CN1058620C true CN1058620C (en) | 2000-11-22 |
Family
ID=5082137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95119652A Expired - Fee Related CN1058620C (en) | 1995-11-12 | 1995-11-12 | Yingfengaidi medicine and its production process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058620C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO864097A0 (en) | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
| IL135620A0 (en) | 1997-10-15 | 2001-05-20 | Polarx Biopharmaceuticals Inc | Compositions and methods for the treatment of primary and metastic neoplastic diseases using arsenic compounds |
| EP2255800B1 (en) | 1997-11-10 | 2012-10-17 | Memorial Sloan Kettering Cancer Center | Arsenic trioxide for use in the treatment of leukaemia |
| CN1233476A (en) | 1998-04-24 | 1999-11-03 | 陆道培 | Medicine for treating acute leukemia, and method for preparing same |
| AUPQ801700A0 (en) | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| AUPQ923100A0 (en) | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
| GB2387780A (en) * | 2002-04-23 | 2003-10-29 | Chaudhry Zamir Ahmad | Herbal composition |
| US8106092B2 (en) | 2004-12-13 | 2012-01-31 | Leo Laboratories Limited | Treatment of solid cancers |
| CN102920758B (en) * | 2012-10-19 | 2014-11-05 | 遵义市成云中医药研究所 | Chinese medicinal preparation for treating anal fistula and preparation method of Chinese medicinal preparation |
| CN103933107A (en) * | 2014-03-28 | 2014-07-23 | 赵保善 | Gamboge rosin plaster external-use patch capable of attacking cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1078635A (en) * | 1992-05-14 | 1993-11-24 | 包鸿延 | A kind of compound method for the treatment of leukemia Chinese medicine |
| CN1085791A (en) * | 1993-07-30 | 1994-04-27 | 高峰 | Medicine of a kind of strengthening bone, pain killing and removing blood stasis and preparation method thereof |
| CN1088449A (en) * | 1993-08-16 | 1994-06-29 | 付耀华 | Cancer pain curing medicine and preparation method thereof |
-
1995
- 1995-11-12 CN CN95119652A patent/CN1058620C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1078635A (en) * | 1992-05-14 | 1993-11-24 | 包鸿延 | A kind of compound method for the treatment of leukemia Chinese medicine |
| CN1085791A (en) * | 1993-07-30 | 1994-04-27 | 高峰 | Medicine of a kind of strengthening bone, pain killing and removing blood stasis and preparation method thereof |
| CN1088449A (en) * | 1993-08-16 | 1994-06-29 | 付耀华 | Cancer pain curing medicine and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1131037A (en) | 1996-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1058620C (en) | Yingfengaidi medicine and its production process | |
| CN103055222A (en) | Medicine for treating tinea manus and pedis | |
| CN1183919C (en) | Cancer treating medical composition | |
| CN1270746C (en) | Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation | |
| CN1250264C (en) | Capsule for curing hyperplasia of mammary glands and its preparation method | |
| CN1188153C (en) | Medicines for treating cancers and tumours | |
| CN1050292C (en) | Anticancer drug and preparing method thereof | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN1252301A (en) | Cancer eliminating ointment compounding process | |
| CN1157219C (en) | Medicine for treating cancer | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN1628826A (en) | Medicine for treating cancer | |
| CN1059833C (en) | Anticancer medicine and its preparation | |
| CN1733197A (en) | Medicine for curing chronic prostatitis and process for preparing the same | |
| CN1679908A (en) | Chinese medicine for treating tumor and preparation thereof | |
| CN1438027A (en) | Chinese medicine for treating breast disease | |
| CN1194717C (en) | Snake poison capsule for treating lung cancer and its preparation method | |
| CN1899558A (en) | Medicinal composition for treating gastropathy and its preparing method and use | |
| CN1836683A (en) | Medicine for treating tumour and its preparing method | |
| CN1569085A (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN1304043C (en) | Longhedan pills and their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |